Literature DB >> 3162361

Centralisation of treatment and survival rates for cancer.

C A Stiller1.   

Abstract

Between 1977 and 1984 the proportion of children with malignant disease in Britain initially referred to specialist paediatric oncology centres increased from 44% to 71%. The percentage varied considerably with type of disease and region of residence. Children with acute non-lymphoblastic leukaemia, non-Hodgkin's lymphoma, Ewing's tumour, rhabdomyosarcoma, and (during 1981-84) osteosarcoma treated at paediatric oncology centres had significantly higher survival rates than those treated elsewhere. Children with cancer should be referred to specialist centres so that they may benefit as early as possible from the latest advances in treatment.

Entities:  

Mesh:

Year:  1988        PMID: 3162361      PMCID: PMC1779345          DOI: 10.1136/adc.63.1.23

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Wilms' tumor in New York State: epidemiology and survivorship.

Authors:  M Griffel
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

2.  Rare cancers and specialist centres.

Authors:  R T Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

3.  Influence of place of treatment on diagnosis, treatment, and survival in three pediatric solid tumors.

Authors:  S Kramer; A T Meadows; G Pastore; P Jarrett; D Bruce
Journal:  J Clin Oncol       Date:  1984-08       Impact factor: 44.544

4.  Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial.

Authors:  E L Lennox; C A Stiller; P H Jones; L M Wilson
Journal:  Br Med J       Date:  1979-09-08

5.  A proposed staging for children with neuroblastoma. Children's cancer study group A.

Authors:  A E Evans; G J D'Angio; J Randolph
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

6.  Survival in childhood acute lymphocytic leukemia: effect of protocol and place of treatment.

Authors:  A T Meadows; S Kramer; R Hopson; E Lustbader; P Jarrett; A E Evans
Journal:  Cancer Invest       Date:  1983       Impact factor: 2.176

7.  Financial burden of childhood cancer.

Authors:  C M Bodkin; T J Pigott; J R Mann
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-22

8.  Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG).

Authors:  M G Mott; J M Chessells; M L Willoughby; J R Mann; P H Morris-Jones; J S Malpas; M K Palmer
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

9.  High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.

Authors:  J Pritchard; T J McElwain; J Graham-Pole
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  35 in total

Review 1.  Shared care--is it worth it for the patient?

Authors:  Iolo Doull
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Treatment protocols, specialist centers, and end results.

Authors:  C A Stiller
Journal:  BMJ       Date:  1990-01-06

Review 3.  Childhood cancer: cure at what cost?

Authors:  P H Morris-Jones; A W Craft
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

Review 4.  Management of lung cancer.

Authors:  M F Muers; R A Haward
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

5.  Do treatment protocols improve end results?

Authors:  M McCarthy
Journal:  BMJ       Date:  1989-11-18

6.  Survival of patients with cancer.

Authors:  C A Stiller
Journal:  BMJ       Date:  1989-10-28

7.  Care models and associated outcomes in congenital heart surgery.

Authors:  Danielle S Burstein; Jeffrey P Jacobs; Jennifer S Li; Shubin Sheng; Sean M O'Brien; Anthony F Rossi; Paul A Checchia; Gil Wernovsky; Karl F Welke; Eric D Peterson; Marshall L Jacobs; Sara K Pasquali
Journal:  Pediatrics       Date:  2011-05-16       Impact factor: 7.124

Review 8.  Assessment of chemotherapy-associated nephrotoxicity in children with cancer.

Authors:  R Skinner; A D Pearson; M G Coulthard; A W Skillen; A W Hodson; M E Goldfinch; I Gibb; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

9.  Pediatric oncology in India: Past, present and future.

Authors:  Brijesh Arora; Sripad D Banavali
Journal:  Indian J Med Paediatr Oncol       Date:  2009-10

10.  Causes of death in children diagnosed with non-Hodgkin's lymphoma between 1974 and 1985.

Authors:  C M Robertson; C A Stiller; J E Kingston
Journal:  Arch Dis Child       Date:  1992-11       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.